What is the purpose of this $1.5 billion note issuance?

The filing does not explicitly state the exact use of proceeds. However, debt issuances of this magnitude are typically used for general corporate purposes, which can include funding operations, capital expenditures, acquisitions, refinancing existing debt, or returning capital to shareholders.

What is the interest rate and maturity date of these new notes?

The notes have a fixed interest rate of 6.125% and will mature on September 15, 2039. This represents a long-term debt obligation for the company.

How much money will CVS Health actually receive after expenses?

After deducting underwriting discounts, commissions, and estimated offering expenses, CVS Health expects to receive approximately $1.48 billion from the $1.5 billion note issuance.

Is this a new type of debt offering for CVS Health?

This specific issuance is for a new series of notes due in 2039. However, the company has an existing shelf registration statement (Form S-3) from 2007, indicating a history of utilizing public markets for debt financing as needed.

CVS 8-K SEC Disclosure — Sep 11, 2009

Summary

CVS Health Corporation (CVS) announced on September 10, 2009, that it entered into an Underwriting Agreement to issue and sell $1.5 billion of 6.125% notes due September 15, 2039. The offering was made under the company's existing shelf registration statement filed in May 2007. The net proceeds from this debt issuance are expected to be approximately $1.48 billion, after deducting underwriting discounts, commissions, and estimated expenses. The closing of this debt offering was scheduled for September 11, 2009. The notes will be governed by a Senior Indenture dated August 15, 2006, with The Bank of New York Trust Company, N.A. as trustee. This financing provides CVS Health with significant capital, which investors may consider in relation to the company's ongoing operational needs, strategic investments, or debt management.

Key Highlights

1CVS Health is issuing $1.5 billion in aggregate principal amount of notes.
2The notes carry a coupon rate of 6.125% and mature on September 15, 2039.
3The net proceeds from the issuance are approximately $1.48 billion.
4The debt offering was conducted under a shelf registration statement filed previously.
5The closing of the note sale was scheduled for September 11, 2009.
6The notes are governed by a Senior Indenture dated August 15, 2006.

CVS HEALTH Corp 8-K Report, Corporate Update (Sep 11, 2009)

Summary

Key Highlights

Frequently Asked Questions